The results demonstrated cytostatic efficacy in PDAC cells expressing EphA4, both in vitro and in orthotopic pancreatic cancer models, by suppressing the phosphorylation of EphA4 and Akt, and inducing apoptosis. Here, EPHA4 is linked to familial pancreatic carcinoma.